JCO Global Oncology (Nov 2020)

High-Cost Cancer Treatment Across Borders in Conflict Zones: Experience of Iraqi Patients in Lebanon

  • Mac Skelton,
  • Raafat Alameddine,
  • Omran Saifi,
  • Miza Hammoud,
  • Maya Zorkot,
  • Marilyne Daher,
  • Maya Charafeddine,
  • Sally Temraz,
  • Ali Shamseddine,
  • Layth Mula-Hussain,
  • Mohammed Saleem,
  • Kazim F. Namiq,
  • Omar Dewachi,
  • Ghassan Abu Sitta,
  • Zahi Abdul-Sater,
  • Talar Telvizian,
  • Walid Faraj,
  • Deborah Mukherji

DOI
https://doi.org/10.1200/JGO.19.00281
Journal volume & issue
no. 6
pp. 59 – 66

Abstract

Read online

PURPOSE Conflict-induced cross-border travel for medical treatment is commonly observed in the Middle East. There has been little research conducted on the financial impact this has on patients with cancer or on how cancer centers can adapt their services to meet the needs of this population. This study examines the experience of Iraqi patients seeking care in Lebanon, aiming to understand the social and financial contexts of conflict-related cross-border travel for cancer diagnosis and treatment. PATIENTS AND METHODS After institutional review board approval, 60 Iraqi patients and caregivers seeking cancer care at a major tertiary referral center in Lebanon were interviewed. RESULTS Fifty-four respondents (90%) reported high levels of financial distress. Patients relied on the sale of possessions (48%), the sale of homes (30%), and vast networks to raise funds for treatment. Thematic analysis revealed several key drivers for undergoing cross-border treatment, including the conflict-driven exodus of Iraqi oncology specialists; the destruction of hospitals or road blockages; referrals by Iraqi physicians to Lebanese hospitals; the geographic proximity of Lebanon; and the lack of diagnostic equipment, radiotherapy machines, and reliable provision of chemotherapy in Iraqi hospitals. CONCLUSION As a phenomenon distinct from medical tourism, conflict-related deficiencies in health care at home force patients with limited financial resources to undergo cancer treatment in neighboring countries. We highlight the importance of shared decision making and consider the unique socioeconomic status of this population of patients when planning treatment.